Clino Corporation collaborates with laboratory animal manufacturers to support non-clinical testing and evaluations using laboratory mini-pigs. This page will walk you through some of the key features of Clino Corporation’s non-clinical study capability, examples of disease models, and related case studies. It serves as a useful guide for selecting a CRO for non-clinical studies.
Clino Corporation specializes in non-clinical studies using large animals that enable testing under conditions similar to humans. In pharmaceutical and medical device development, large-animal testing plays an essential role in evaluating human-like reactions and device performance, which cannot be replicated in small animals such as rats or mice. While large-animal testing typically requires dedicated facilities, expert knowledge, and significantly higher cost, Clino Corporation overcomes these challenges through its nationwide coordination network, comprehensive animal management, and the supply of Micro Minipigs®. These capabilities ensure high-quality and reliable non-clinical studies.
Leveraging its extensive domestic network, Clino Corporation provides comprehensive support in both study coordination and animal welfare before, during, and after the testing. This comprehensive one-stop service structure enables efficient and high-quality study execution while minimizing administrative tasks.
Clino Corporation supplies the Micro Minipig®, one of the world’s smallest breeds of laboratory pigs developed in Japan. By utilizing this unique resource, the company offers non-clinical studies that closely mimic human physiology, earning strong recognition in the pharmaceutical and medical device sectors.
Fuji Micra has independently developed ultra-small experimental pigs that weigh under 10 kg and measure less than 80 cm in length at six months of age—small enough to be housed in standard dog cages. Other disease models including atherosclerosis and chronic renal failure Micro Minipigs are available.
No case studies are currently listed on the official website.
Clino originated as part of the research team within the Tohoku University Advanced Biomedical Engineering Research Organization, established in 2003 under the Ministry of Education, Culture, Sports, Science and Technology (MEXT) “Super COE” program (completed in 2008).
| Address | Collaboration Building, Aobayama Office, Research Center for Accelerator and Radioisotope Science (RARiS), Tohoku University, 6-3 Aoba, Aramaki Aza, Aoba-ku, Sendai, Miyagi, Japan |
|---|---|
| Tel | 050-3716-5633 |
| Website | https://www.clino.org/ |
In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D.
In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening.
Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.